|
|
|
Volumn 25, Issue 5 SUPPL. 12, 1998, Pages 12-17
|
|
Evolution in the treatment of advanced breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
IFOSFAMIDE;
METHOTREXATE;
MITOMYCIN C;
MITOXANTRONE;
PACLITAXEL;
VINBLASTINE;
VINCRISTINE;
ADVANCED CANCER;
ARTICLE;
BREAST CANCER;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
EDEMA;
FEMALE;
HUMAN;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CLINICAL TRIALS;
DOXORUBICIN;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0031774903
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (33)
|
|
References (60)
|
